文献速递糖尿病肥胖与代谢综合征

术前循环琥珀酸水平作为减重手术后糖尿病缓解的生物标志物

Preoperative Circulating Succinate Levels as a Biomarker for Diabetes Remission After Bariatric Surgery.
PubMed 文献 · Diabetes Care · 2019-08-02

基线琥珀酸浓度是糖尿病缓解的独立预测因子,缓解者基线琥珀酸较低(47.8 vs 64.1 µmol/L,P=0.018),术后1年琥珀酸显著下降(58.9 vs 46.0 µmol/L,P=0.005)。多变量模型包含基线琥珀酸(OR 11.3)和手术类型(OR 26.4),推导队列C统计量0.899,验证队列0.729。

要点

  • 基线琥珀酸较低者减重术后1年糖尿病缓解率更高。
  • 减重术后1年循环琥珀酸水平较基线显著下降。
  • 基线琥珀酸联合手术类型可提升现有评分对缓解的预测能力。

核心结论

  • 循环琥珀酸在减重手术后降低,基线琥珀酸水平对糖尿病缓解有独立预测价值,并改善现有评分的预测能力。

研究设计与样本

  • 外部验证队列88例肥胖糖尿病患者根据临床标准分配至RYGB或SG。

主要发现

  • 达到缓解者基线琥珀酸较低:47.8 [37.6-64.6] µmol/L vs 64.1 [52.5-82.9] µmol/L,P=0.018。
  • 术后1年琥珀酸显著下降:58.9 [46.4-82.4] µmol/L vs 46.0 [35.8-65.3] µmol/L,P=0.005。
  • 多变量分析中基线琥珀酸(OR 11.3,P=0.031)和手术类型(OR 26.4,P=0.010)与缓解独立相关。
  • 模型C统计量推导队列0.899(95%CI 0.809-0.989),验证队列0.729(95%CI 0.612-0.846)。
  • 根据基线琥珀酸水平,患者对不同手术类型的缓解率反应存在显著差异。

关键数值与推荐

  • 基线琥珀酸是糖尿病缓解的独立预测因子,缓解者基线值更低(P=0.018)。
  • 多变量模型中基线琥珀酸OR 11.3(P=0.031),手术类型OR 26.4(P=0.010)。

临床怎么用

  • 可考虑检测基线循环琥珀酸水平辅助预测减重术后糖尿病缓解概率。
  • 结合基线琥珀酸与计划手术类型个体化评估减重手术的糖尿病缓解预期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the potential use of baseline circulating succinate to predict type 2 diabetes remission after bariatric surgery. RESEARCH DESIGN AND METHODS: Forty-five obese patients with diabetes were randomly assigned to Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), or laparoscopic greater curvature plication. Anthropometric parameters were evaluated, and a complete biochemical analysis including circulating serum succinate concentrations was performed at baseline and 1 year after surgery. The results were externally validated in a second cohort including 88 obese patients with diabetes assigned to RYGB or SG based on clinical criteria. RESULTS: Succinate baseline concentrations were an independent predictor of diabetes remission after bariatric surgery. Patients achieving remission after 1 year had lower levels of baseline succinate (47.8 [37.6-64.6] µmol/L vs. 64.1 [52.5-82.9] µmol/L; P = 0.018). Moreover, succinate concentrations were significantly decreased 1 year after surgery (58.9 [46.4-82.4] µmol/L vs. 46.0 [35.8-65.3] µmol/L, P = 0.005). In multivariate analysis, the best logistic regression model showed that baseline succinate (odds ratio [OR] 11.3, P = 0.031) and the type of surgery (OR 26.4, P = 0.010) were independently associated with remission. The C-statistic for this model was 0.899 (95% CI 0.809-0.989) in the derivation cohort, which significantly improved the prediction of remission compared with current available scores, and 0.729 (95% CI 0.612-0.846) in the validation cohort. Interestingly, patients had a different response to the type of surgery according to baseline succinate, with significant differences in remission rates. CONCLUSIONS: Circulating succinate is reduced after bariatric surgery. Baseline succinate levels have predictive value for diabetes remission independently of previously described presurgical factors and improve upon the current available scores to predict remission.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Ceperuelo-Mallafré V, Llauradó G, Keiran N, et al. Preoperative Circulating Succinate Levels as a Biomarker for Diabetes Remission After Bariatric Surgery. Diabetes Care. 2019. PMID: 31375523. doi:10.2337/dc19-0114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。